Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Initial clinical experiences with a transvenous-subcutaneous defibrillation system].

M Block1, D Hammel, M Borggrefe

  • 1Medizinische Klinik und Poliklinik, Innere Medizin C, Westfälische Wilhelms-Universität Münster.

Zeitschrift Fur Kardiologie
|November 1, 1991
PubMed
Summary

This study shows that transvenous-subcutaneous leads for implantable defibrillators are effective and safe, avoiding thoracotomy in most patients with ventricular tachyarrhythmias.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Influence of waveform and configuration of electrodes on the defibrillation threshold of implantable cardioverter-defibrillators].

Herzschrittmachertherapie & Elektrophysiologie·2009
Same author

The coronary-subclavian-vertebral steal syndrome (CSVSS).

Clinical research in cardiology : official journal of the German Cardiac Society·2006
Same author

Potential benefit from implantable cardioverter-defibrillator therapy in children and young adolescents.

Heart (British Cardiac Society)·2004
Same author

[Aneurysm of the subclavian artery after operatively corrected coarctation of the aorta: 20 years of follow-up and review of the current literature].

Zeitschrift fur Kardiologie·2003
Same author

Congenital aortic regurgitation due to absent aortic cusps and high-degree mitral stenosis.

Pediatric cardiology·2003
Same author

Uniform long-term gene expression using adeno-associated virus (AAV) by ex vivo recirculation in rat-cardiac isografts.

The Thoracic and cardiovascular surgeon·2002

Area of Science:

  • Cardiology
  • Biomedical Engineering

Context:

  • Implantable defibrillators (ICDs) are crucial for managing life-threatening ventricular tachyarrhythmias.
  • Traditional implantation often requires thoracotomy, a procedure associated with significant morbidity.
  • Minimally invasive techniques are sought to improve patient outcomes and reduce procedural risks.

Purpose:

  • To evaluate the feasibility and efficacy of a novel transvenous-subcutaneous lead system for implantable defibrillators.
  • To assess the defibrillation threshold, lead system performance, and complication rates in patients avoiding thoracotomy.

Summary:

  • A transvenous-subcutaneous lead system was implanted in 17 out of 19 patients indicated for an implantable defibrillator, successfully avoiding thoracotomy.
  • The system demonstrated a sufficient defibrillation threshold in most patients, with no lead malfunctions observed during a 7-month follow-up.

Related Experiment Videos

  • All 68 spontaneous ventricular tachyarrhythmia episodes were successfully terminated, highlighting the system's efficacy.

    • Impact:

    • This approach offers a viable alternative to thoracotomy for implantable defibrillator implantation, particularly in high-risk patients.
    • The transvenous-subcutaneous lead system shows excellent long-term efficacy and a favorable safety profile.
    • Successful defibrillation and rapid patient mobilization suggest improved patient management and recovery.